Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 70 years of age
- People whose primary language is English
- People who have been formally diagnosed with multiple sclerosis (MS) by a neurologist
- People who have not had a relapse or taken steroids for at least 30 days
- People with mild-to-moderate self-reported difficulty with movement or mobility, based on a specific MS disability scale (called the PDDS)
- People who are currently not regularly physically active, based on a standard exercise questionnaire (called the GLTEQ)
- People who are right-handed
Who may not be able to join:
- People who have a history of neurological conditions other than MS, or who have uncontrolled mental health conditions such as major depression
- People for whom exercise may not be medically safe, based on a standard health screening questionnaire (called the PAR-Q)
- People who are currently taking medications that could affect thinking or memory, such as steroids or benzodiazepines
- People who are currently pregnant
- People who cannot safely have an MRI scan, such as those with certain metal implants or electronic devices in their body that are not considered MRI-safe
- People with severe difficulties with thinking or memory, as measured by a specific cognitive screening tool (called the TICS-M)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carly Wender, PhD, Kessler Foundation
Phone: (973) 324-8388
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in objective new learning and memory (NLM).; Change in everyday memory
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.